MedPath

Octagam Immune Globulin (Human)

Octagam, Immune Globulin Intravenous (Human) 5% Liquid Preparation Initial U.S. Approval: 2004 - These highlights do not include all the information needed to use Octagam, Immune Globulin Intravenous (Human), safely and effectively. See full prescribing information for Octagam.

Approved
Approval ID

810c8752-a7cb-0bce-777d-8539429773c2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 9, 2009

Manufacturers
FDA

Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.

DUNS: 301119178

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Immune Globulin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67467-843
Application NumberBLA125062
Product Classification
M
Marketing Category
C73585
G
Generic Name
Immune Globulin
Product Specifications
Route of AdministrationIntravenous
Effective DateSeptember 9, 2009
FDA Product Classification

INGREDIENTS (1)

HUMAN IMMUNOGLOBULIN GActive
Quantity: 50 mg in 1 mL
Code: 66Y330CJHS
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Octagam Immune Globulin (Human) - FDA Drug Approval Details